Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesPersons encountering health services for examinationsICD-10-CM z08-encounter-for-follow-up-malignant-neoplasm
    Ask Trek AI about this page

    ICD-10-CM Code For Encounter For Follow-Up Examination After Completed Treatment For Malignant Neoplasm: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group Z08 includes codes for encounters for follow-up examinations after completed treatment for malignant neoplasms, covering surveillance visits to assess for recurrence, residual effects, or treatment complications. These ICD-10-CM diagnosis codes are used to document post-treatment surveillance visits, capturing the focus on cancer follow-up rather than active treatment, and may reflect the organ system previously involved or the need for specific monitoring. Accurate coding within the ICD-10-CM Z08 group supports proper claim adjudication and complete clinical documentation.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Encounter For Follow-Up Examination After Completed Treatment For Malignant Neoplasm: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM Z08: Encounter For Follow-Up Examination After Completed Treatment For Malignant Neoplasm Overview

    The Z08 codes represent encounters for follow-up examinations after a patient has completed treatment for a malignant neoplasm. These codes target oncology surveillance across organ systems previously affected by cancer and are used when the purpose of the visit is monitoring for recurrence, residual effects, or complications. Accurate coding matters for appropriate claim processing and to reflect continuity of care after cancer treatment.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when a patient presents for a scheduled follow-up visit after completing definitive treatment for a malignant neoplasm and the visit is for surveillance or evaluation of post-treatment status. These codes are appropriate when there is no active treatment for cancer at the time of the encounter and the purpose is monitoring or assessing residual issues.

    ICD-10-CM Codes

    1 rows

    ICD-10-CM CodeDescription
    Z08Encounter for follow-up examination after completed treatment for malignant neoplasm

    DRG Codes

    11 rows

    DRG CodeDescription
    826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCC
    827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CC
    828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCC
    829Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures with CC/MCC
    830Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Other Procedures without CC/MCC
    837Chemotherapy with Acute Leukemia as Secondary Diagnosis or with High Dose Chemotherapy Agent with MCC
    838Chemotherapy with Acute Leukemia as Secondary Diagnosis with CC or High Dose Chemotherapy Agent
    839Chemotherapy with Acute Leukemia as Secondary Diagnosis without CC/MCC
    846Chemotherapy without Acute Leukemia as Secondary Diagnosis with MCC
    847Chemotherapy without Acute Leukemia as Secondary Diagnosis with CC
    848Chemotherapy without Acute Leukemia as Secondary Diagnosis without CC/MCC

    Typical Clinical Scenarios

    • An adult patient who completed definitive treatment (surgery with adjuvant chemotherapy) for stage II colon cancer now presents for a routine surveillance visit with no current symptoms; history, interval exam, and surveillance imaging/laboratory tests are ordered to monitor for recurrence. A code from this group is assigned to indicate the encounter is for follow-up examination after completed treatment for malignant neoplasm. Typical codes: Z08.
    • A middle-aged breast cancer survivor who finished lumpectomy and radiation six months ago arrives urgently with a new palpable lump at the surgical site; the visit documents evaluation to distinguish recurrence from benign postsurgical changes, with biopsy planned. The encounter is coded from this group to reflect follow-up assessment after completed cancer treatment while investigating a potential complication or suspected recurrence. Typical codes: Z08.
    • An elderly patient with a prior history of treated non-small cell lung cancer in remission attends a scheduled long-term survivorship visit for functional assessment and management of late effects (pulmonary function testing and medication review) despite stable imaging. The visit is coded from this group to denote a surveillance follow-up after completed malignant neoplasm treatment as part of ongoing survivorship care. Typical codes: Z08.

    Related Codes

    Z00-ENCOUNTER-FOR-GENERAL-EXAMINATION

    ICD-10-CM Code For Encounter For General Examination Without Complaint Suspected Or Reported Diagnosis: Group Overview

    Z01-ENCOUNTER-FOR-OTHER-SPECIAL-EXAMINATION

    ICD-10-CM Code For Encounter For Other Special Examination Without Complaint, Suspected Or Reported Diagnosis: Group Overview

    Z02-ENCOUNTER-FOR-ADMINISTRATIVE-EXAMINATION

    ICD-10-CM Code For Encounter For Administrative Examination: Group Overview

    Z03-ENCOUNTER-FOR-MEDICAL-OBSERVATION

    ICD-10-CM Code For Encounter For Medical Observation For Suspected Diseases And Conditions Ruled Out: Group Overview

    Z04-ENCOUNTER-FOR-EXAMINATION-AND-OBSERVATION

    ICD-10-CM Code For Encounter For Examination And Observation For Other Reasons: Group Overview

    Z05-ENCOUNTER-FOR-NEWBORN-OBSERVATION

    ICD-10-CM Code For Encounter For Observation And Evaluation Of Newborn For Suspected Diseases And Conditions Ruled Out: Group Overview

    Z09-ENCOUNTER-FOR-FOLLOW-UP

    ICD-10-CM Code For Encounter For Follow-Up Examination After Completed Treatment For Conditions Other Than Malignant Neoplasm: Group Overview

    Z11-ENCOUNTER-FOR-SCREENING

    ICD-10-CM Code For Encounter For Screening For Infectious And Parasitic Diseases: Group Overview

    Z12-ENCOUNTER-FOR-SCREENING-MALIGNANT-NEOPLASMS

    ICD-10-CM Code For Encounter For Screening For Malignant Neoplasms: Group Overview

    Z13-ENCOUNTER-FOR-SCREENING

    ICD-10-CM Code For Encounter For Screening For Other Diseases And Disorders: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.